Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer

Phase 2 Terminated 39 enrolled Mayo Clinic National Cancer Institute (NCI) · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

This phase II trial studies how well Polyphenon E works in treating patients with high-risk of colorectal cancer. Polyphenon E contains ingredients that may prevent or slow colorectal cancer.

Timeline

Start: 2012-06
Primary completion: 2015-05-21
Completion: 2015-05-21

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sinecatechins	Unknown	400 mg	Oral

Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer

Summary

Timeline

Drugs

Indications